Form 8-K - Current report:
SEC Accession No. 0001437749-24-002036
Filing Date
2024-01-24
Accepted
2024-01-24 16:00:39
Documents
13
Period of Report
2024-01-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20240122_8k.htm   iXBRL 8-K 24042
  Complete submission text file 0001437749-24-002036.txt   155021

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA opk-20240122.xsd EX-101.SCH 3401
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20240122_def.xml EX-101.DEF 11421
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20240122_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20240122_pre.xml EX-101.PRE 11581
7 EXTRACTED XBRL INSTANCE DOCUMENT opk20240122_8k_htm.xml XML 2539
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 24556377
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)